Nanocarry Therapeutics
PrivateLast Round
Grant
Jan 1, 2024
Total Funding Raised
$1M
Company Overview
Nanocarry Therapeutics is a biopharmaceutical company developing a nanoparticle delivery platform to transport therapeutics across the blood-brain barrier for oncology and central nervous system diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Advanced Materials, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nanocarry Therapeutics Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Nanocarry Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jan 1, 2024 | ||||
| Pre Seed | Oct 1, 2021 |
Key People
Founding team and executive leadership
Nanocarry Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NFX | Pre Seed |
| Unbox Ventures | Pre Seed |
| Israel Innovation Authority | Grant, Pre Seed |
| Sapir Venture Partners | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 19, 2025
Grew 38% QoQ from 8 to 11 employees.
- Mar 21, 2025
Grew 57% QoQ from 7 to 11 employees.
Nanocarry Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Nanocarry Therapeutics's valuation, stock price, and market status.